Methylene Blue

Methylthioninium Chloride, the active ingredient in Methylene Blue, is a thiazine dye presented as an intravenous solution for intravenous use. It is employed to treat methemoglobinemia, cyanide poisoning, and certain drug‑induced toxicities in emergency and clinical settings.

GNH USA supplies Methylene Blue as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Methylene Blue acts on hemoglobin and cellular enzymes to reverse toxic metabolic states. It is indicated for: - Methemoglobinemia: rapidly reduces methemoglobin back to functional hemoglobin. - Cyanide poisoning: assists in detoxifying cyanide complexes. - Ifosfamide‑induced neurotoxicity: mitigates encephalopathic symptoms. - Diagnostic staining procedures: provides visual contrast for laboratory and surgical applications.

Methylene Blue may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Blue‑green discoloration of urine. - Mild nausea or gastrointestinal upset. - Headache. - Transient hypertension.

Serious or Rare Side Effects: - Severe hemolysis in patients with G6PD deficiency. - Anaphylactic or severe allergic reaction. - Paradoxical increase in methemoglobin levels. - Serotonin syndrome when combined with serotonergic agents.

Use of Methylene Blue requires careful assessment of patient risk factors and proper handling. - G6PD deficiency: avoid use due to risk of hemolysis. - Pregnancy: administer only if potential benefit justifies potential risk. - Renal impairment: monitor renal function and adjust therapy as needed. - Concomitant serotonergic drugs: assess for serotonin syndrome risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methylene Blue can interact with several medications, necessitating vigilance.

Major Interactions (Avoid): - Serotonergic agents (SSRIs, MAOIs, tramadol): risk of serotonin syndrome. - G6PD‑deficient patients: heightened hemolysis risk. - High‑dose nitrites: may exacerbate methemoglobinemia.

Moderate Interactions (Monitor Closely): - Phenothiazines: may potentiate hypotensive effects. - Beta‑blockers: monitor blood pressure closely. - Renal replacement therapy: may alter drug clearance, requiring dose adjustment.